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ABSTRACT 
A 27 years old non diabetic, normotensive, female had undergone lower segment caesarean section (LSCS) with tubular ligation. She complained 
discharge at left side of stitch line after about 5 weeks of operation, and was treated with broad spectrum antibiotics. As she did not improve, 
first and second debridement was done in January and February 2017 and pyogenic cultures sent were sterile. Later she was advised for 
Multiple detector computed tomography (MDCT) in March 2017, which revealed accumulations in pre-peritoneal space of urinary bladder 
posteriorly and reached to anterior wall of uterus. This pus was from multiple sinuses and were sent for mycobacterial cultures which showed 
growth of MOTT- M. mageritense further identified by MALDI-TOF and supported by molecular technologies. After identification of this Non-
tuberculosis mycobacteria (NTM). She was treated for the same and recovered completely after seven months of anti-NTM treatment. This is the 
first reported case of M. mageritense in skin and soft tissue in India. Literature also reports a few cases around the globe.  
Keywords: Mycobacterium mageritanse, Tubular ligation Lower segment Cesarian section (LSCS), Microbial culture, Rapid molecular 
techniques, MDCT, antibiotic treatment. 
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INTRODUCTION  
Mycobacterium mageritense, belongs to non tuberculosis 
mycobacterial group. It is similar to rapidly growing 
pigmentation types, which has a close resemblance to M. 
fortuitum complex1, 2. It causes human disease like 
furunuculosis, which was reported by Gira et al 3 and 
Winthrop       et al 4 detected this bacteria in cases working in 
nail salon where they received foot-baths prior to pedicures. 
The above microbe was isolated by pulsefield gel 
electrophoresis including environmental isolates and water 
5, 6. Two isolates of sputum in Spain, six strains from USA, 
isolated from sputum, bronchial fluid, blood, sinus drainage 
and surgical wound infection were noticed. These were also 
similar to that of M. fortuitum third biovariant complex 7-9. 
Isolation of these bacteria from lung of a harbor porpoise 
with severe granulomatous lesions was causative agent for 
its death10. There have been few reports in relation to skin 
and soft tissue infections due to these bacteria outside India 
3,6,7,11,12.  
Studies on Post-surgical inoculation wound infection / Post 
infection abscess in India have isolated NTM from various 
sites like skin and soft tissue after laparoscopic procedure. 
Typical manifestation is post laparoscopic non healing 
wound since months or years, resulting in chronic discharge 
sinus tracts. The discharge is usually serous in nature. The 
lesions are usually painless. Fever is usually absent. 
Empirical antibiotics and antituberculous agents are tried 
without much benefit in such cases. Hence, this study was 
undertaken to report the first case with M. mageritense from 
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soft tissue at surgical site during tubular ligation of a case 
from India.        
CASE REPORT 
A 27 old woman underwent LSCS with tubular ligation on 9th 
October 2016. About 5 weeks, she complained of discharge 
from left side of stitch line. She was then treated with 
antibiotics and daily dressing. Antibiotics were Tab. 
Cephalaxin for 15 days, Tab. Cefexime for 10 days and Tab. 
Amoxicillin with clavulinic acid for 7 days. Since, she did not 
improve; first debridement was done in January.2017, 
followed by second debridement in February 2017.Pus sent 
for pyogenic culture gave negative report. The Gram stain 
and ZN stain were reported negative. Both debridements 
were done at sub district place. Then MDCT was advised. It 
revealed collection accumulated in a well near infraumbical 
region, reaching urinary bladder posteriorly and uterine wall 
interiorly. Other organs like liver, spleen, kidney and urinary 
bladder appeared normal. However, the thick walled 
loculated (pus) collections in anterior abdominal wall and 
subcutaneous plane in infraumbilical region reaching into 
extra peritoneal space of pelvic cavity up to anterior wall of 
uterus were used for cultures and rapid molecular 
techniques to detect specific mycobacterium causing 
infection at surgical site. Latest diagnostic technologies were 
used for precise identification of the isolate at Supratech 
Micropath Laboratory and Research Institute, Ahmedabad13. 
Following fig.1 
 
Figure 1: Flow chart of series of events from surgery to 
recovery 
MATERIALS AND METHODS 
Microbiological Examination 
Potassium hydroxide (KOH) (10%) examination was done on 
tissue slide and was examined to identify fungal elements. 
Gram stain procedure was adopted for detecting gram 
positive and gram negative bacteria in our sample following 
standard method in our laboratory. Ziehl–Neelsen stain 
(ZNCF) stain was also performed on the specimen to detect 
presence of AFB. Further pyogenic culture was performed by 
standard method following the protocol in our laboratory, 
whereas the fungus culture was included and incubated at 
two different temperatures 25oc and 35oc to isolate majority 
fungal types. AFB Culture was performed by liquid culture 
medium by MGIT 960.  
LPANTM CM (Line Probe Assays Nontuberculous 
Mycobacteria Common Mycobacteria) 
 The genotype Mycobacterium CM test is based on the DNA-
STRIP technology. The whole procedure is divided into three 
steps involving DNA extraction from   cultured material 
liquid medium, a multiplex amplification with biotinylated 
primers and a reverse hybridization. All reagents needed for 
amplification, such as polymerase and primers, are included 
in the Amplification Mixes A and B (AM-A and AM-B) and are 
optimized for this test. The membrane strips are coated with 
specific probes complementary to the amplified nucleic 
acids. After chemical denaturation, the single-stranded 
amplicons bind to the probes (hybridization). Highly specific 
binding of complementary DNA strands are ensured by 
stringent conditions which result from the combination of 
buffer composition and certain temperature. Thus the 
probes reliably discriminate the different sequences of the 
bacterial species. The streptavidin-conjugated alkaline 
phosphatase binds to the amplicons’ biotin via the 
streptavidin moiety. Finally, the alkaline phosphatase 
transforms an added substrate into a dye which becomes 
visible on the membrane strips as a colored precipitate. A 
template ensures the easy and fast interpretation of the 
banding pattern obtained.  
MALDI-TOF (Matrix Assisted Laser Desorption 
Ionization - Time of Flight)  
It is based on three functional units having ion source, mass 
analyzer and detection device to monitor sample ions which 
follow a simple protocol. The pure growth from positive 
Mycobacteria Growth Indicator Tube (MGIT) culture tube 
was taken as sample identification on MALDI-TOF (Bruker’s 
microflex) to score for detection of the bacteria. 
Molecular analysis 
DNA extraction 
The positive MGIT culture isolate was used as a specimen for 
molecular analysis. Sonicated Mycobacterial cells were use 
for bacterial DNA extraction using manually DNA extraction 
Kit (Roche high pure kit, India). The concentration of DNA 
was determined using the Qubit 4.0 fluorometer HS DNA kit 
(Thermo Fisher Scientific, USA). 
Sanger DNA sequencing 
The 16S rRNA gene was designed to determine properties of 
designed primers14 and also we are using Primer Blast 
(https://www.ncbi.nlm.nih.gov/tools/primer-blast/) to 
check whether our region of interest is covered or not. 
Primers were synthesized at 100pM (Picomole) scale and 
cartridge purified (Eurofins India). Polymerase Chain 
Reaction (PCR) amplification was carried out using rTaq 
Premix Taq Version 2.0 PCR master mix with 8F and 1492R, 
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16S rRNA gene specific primers at 10pM concentration 
under standard conditions. PCR amplifications were all 
carried out in duplicate alongside a known normal control 
cell line sample. Successful PCRs were purified prior to 
sequencing using ExoSAP-IT reagent (Affrymetrix-USA) 
according to the manufacturer’s protocol. Purified PCR 
products were Sanger sequenced in both forward and 
reverse orientations using the same primer sequences used 
for PCR at 10pM final concentration using BigDye® v3.1 
according to manufacturer’s cycling conditions. BigDye® 
v3.1 sequencing reactions were then purified using Ethylene 
diamine tetra acetic Acid (EDTA) and sodium acetate 
according to the manufacturer’s protocol and analyzed on 
3500 Genetic Analyzer (Applied Biosystems USA). Sanger 
sequencing data was analyzed using Codon Code Aligner 
v5.0.2, (Codon Code Corporation Centerville, USA) and NCBI 
blast the entire sequence. 
Next generation sequencing (NGS) 
For targeted NGS analysis, 16S rRNA gene primers were 
used. PCR was performed using 5-15 ng/ μl bacterial DNA 
and   rTaq Premix Taq Version 2.0 PCR master  mix 
(TAKARA) for initial denaturation at 95°C for 10 mins, 
followed by 35 cycles of denatuation at 95°C for 30 sec, 
annealing at 52°C  for 4 min and elongation at 72°C for 2 
mins. Final elongation at 72°C for 10 mins. and holding 
period at 4°C. About1.4 kb PCR amplicons was purified using 
(1.4x) Agencourt AMPure XP reagents (Beckman Coulter, 
USA) to remove the primer dimer. For End repair and 
fragmentation use 100ng/ μl of DNA concentration and 
incubate the end-repair reaction for 20 minutes at room 
temperature using the Ion plus fragment kit (Life 
technology-USA). Amplicons purified using Agencourt 
AMPure XP reagents. The amplicons were ligated to adapters 
with barcodes of the Ion XpressTM Barcode Adapters kit 
(Life Technologies, USA) for 15 mins at 25°C then 72°C for 5 
min and hold at 4°C. Adapter ligated amplicon libraries were 
purified using Agencourt AMPure XP reagents (Beckman 
Coulter, USA). The library concentration was determined 
using an Ion Library Quantitation Kit (Life Technologies, 
USA), then each library was diluted to 4-8 pmol/L and the 
same amount of libraries was pooled for one sequence 
reaction. Next, emulsion PCR was carried out using the Ion 
OneTouchTM 2.0 System and Ion 540TM OT2 Reagents (Life 
Technologies, USA) according to the manufacturer’s 
instructions. Template-positive Ion SphereTM Particles were 
then enriched with Dynabeads MyOneTM Streptavidin C1 
Beads (Life Technologies, USA) using an Ion OneTouchTM ES 
system (Life Technologies, USA). Purified Ion Sphere 
particles were loaded on 540 (Compatible with Ion S5 
System) Chip. Massively parallel sequencing was carried out 
on Ion S5 sequencer (Thermo Fisher, USA) using Ion S5 
Sequencing kit according to the manufacturer’s instructions. 
Sequencing was performed using 500 flow runs that 
generated approximately 200 bp reads. 
Data analysis 
The data generated from the Instruments are transferred to 
the Standalone Torrent Suite (version 5.2) analysis server as 
Direct agglutination test (DAT) files. This DAT files contains 
electrical signals generated during sequencing flow. The 
Torrent Suite software (version 5.2) coverts this electrical 
signals into numerical one and store them in 1.wells files 
during the signal processing step. BaseCaller will read the 
information stored in 1.wells file and covert them into 
sequence of bases and computes the quality scores of each 
base. The next step is barcode filtration and adapter, low 
quality reads, low signal bases trimming. The final data is 
stored in an unaligned Binary Alignment Map (BAM) file 
which can be used for further alignment processes. The 
unaligned BAM files are downloaded from the Torrent Suite 
software (version 5.2) and converted into FASTQ format file 
to run with BWA aligner (version 0.7.12-r1039). Burrows-
Wheeler Aligne (BWA) aligner is used to align the raw reads 
to human reference genome hg19 to remove human reads 
from the data. The unaligned non-human reads are then 
extracted from the BWA output file and stored in BAM 
format file. Newly generated BAM files are then uploaded to 
the standalone Ion Reporter software (version 5.2) for 
identifying the presence of bacterial genome present in the 
data. The uploaded BAM files are run through the 
Metagenomics 16S w1.1workflow of Ion Reporter (version 
5.2) for the identification of species present in the data. 
Simultaneously, the reads in a BAM files are extracted with 
custom script and stored in a Federal Acquisition 
Streamlining Act (FASTA) file for running with standalone 
Basic Local Alignment Search Tool (BLAST) program. The 
standalone blast is run against “nr” database to reconfirm 
the results obtained by Ion Reporter software (version 5.2).  
RESULTS AND DISCUSSION  
M. mageritense was first isolated by Domenech et al1, Similar 
to others like M. fortuitum and M. abscessus. This organism 
is linked with human diseases as reported in USA 3. It is 
rapidly growing bacteria like others and is ubiquitous and 
also usually isolated from Municipal water 2. Few reports 
have also been described of skin and soft tissue infections 
due to this mycobacterium outside India. In our patient, this 
isolate was identified in a patient who underwent LSCS with 
tubular ligation in October 2016. There was disgorge from 
left side of stitch line after 5 weeks of postop period .  
Treatment of broad spectrum antibiotics was given, but 
collection of discharge (pus) persisted even after two 
subsequent debridements in January and February 2017. 
Then MDCT report detected pus in between abdominal 
anterior wall and infraumbilical region reaching to anterior 
wall of uterus. Thus, this isolate was examined using 
microbiological culture tests and molecular techniques. The 
clinical specimen underwent KOH examination; Gram stain 
and ZNCF stain which were negative. Pyogenic and fungus 
culture were also negative. The clinical specimen was run on 
Mycobacteria Growth Indicator Tube (MGIT 960) system, an 
automated liquid media system for AFB culture, which was 
positive for Nontuberculous Mycobacteria other than 
tuberculosis (NTM/MOTT). Gene expert was also negative. 
The pure growth of NTM/MOTT was subjected to LPANTM 
CM, a Line probe assay for identification of common 
NTM/MOTT. The results showed good control bands but did 
not show any relevant conclusive identification bands. 
Further the sample was subjected to MALDI TOF where the 
sample was identified with score of 2.27 as M. mageritense 
(Fig.2). Further the other molecular techniques were 
adopted for genome analysis of these bacteria. The analysis 
of 16s rRNA using Sanger sequencing and Next generation 
Sequencing (NGS) revealed that the two pictures observed in 
both techniques (Figs 3a,3b) were found to be similar to that 
of NCBI strains CS33.1(Fig.4). Similarly the draft genome 
sequence of M. mageritense species/strains DSM 44476T of 
NTM causing various infections was available5. Refined 
analysis incorporating the sequence of 16r RNA and other 
genes indicated that M. mageritense stands by itself as a 
separate species. Our results on 16s rRNA extracted from 
our isolate also indicated the same microbe as cited above. 
All these results indicated that this strain is a novel one 
separate from other types and is the first isolate report in 
India. This investigation thus was further supportive to the 
study of MALDI-TOF. In clinical sites or samples which have 
not responded after multiple uses of broad spectrum 
antibiotics, surgical debriment and these are no positive 
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finding in pyogenic microbiological cultures, a ZN stain and 
AFB culture should be considered. Newer technologies play 
an important role in identification of novel bugs. In this 
MALDI-TOF helped the case in identification the 
mycobacterial species along with molecular technique and 
planning the NTM therapy. Such technologies will also be of 
great help to develop epidemiology of local regions. 
  
 
Figure 2: Report of M. mageritense score from MALDI-TOF 
 
Figure 3a: NCBI Blast from NGS showing sequence of sequence 16S rRNA gene (strain CS33.1). 
 
Figure 3b: IR suite showing species level identification of bacteria 
 
Figure 4: NCBI blast result of Sanger sequencing of strain CS33.1 16s rRNA gene. 
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TREATMENT 
After confirmation of the strain, Cephalaxin, Cefixime and 
Amoxicillin with clavulinic acid viz i.e anti NTM treatment 
for 7 months was suggested for complete recovery. 
CONCLUSION  
Non- NTM strain, M. mageritense was detected in pus 
collected from a well formed from soft tissue as a result of 
left side tubular ligation at site of stitch line (fig 5a). 
Advanced microbiological and molecular techniques, 
confirmed it as M. mageritense and anti-NTM treatment was 
given for seven months for complete recovery (fig 5b). To 
our knowledge, this is the first report of isolating and 
identifying M. mageritense at surgical site of a patient from 
India.
 
      
Figure 5a:  Before treatment                                                    Figure 5b: After treatment 
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